Evaluation of the Coca-Cola Company travel health kit

Journal of Travel Medicine

Volumn 9, Issue 5, 2002, Pages 244-246

  Harper, Lynne A ^a   Julie, Bettinger ^b   Roberta, Dismukes ^c   Kozarsky, Phyllis E ^c  

^a The Coca Cola Company   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTITUSSIVE AGENT; EYE DROPS; GASTROINTESTINAL AGENT; HYPNOTIC SEDATIVE AGENT; VITAMIN; DRUG;

ADULT; ARTICLE; EVALUATION; FIRST AID; HUMAN; INDUSTRY; MALE; NEEDLE; NORMAL HUMAN; PRESCRIPTION; SLEEP; SYRINGE; TECHNICAL AID; TRAVEL; COMMERCIAL PHENOMENA; FEMALE; MIDDLE AGED; QUESTIONNAIRE;

ADULT; COMMERCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; QUESTIONNAIRES; TRAVEL;

EID: 0036709348     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2002.24156     Document Type: Article

References (3)

1. Kemmerer TP, Cetron M, Keystone JS, Kozarsky PE. Health problems of corporate travelers: Risk factors. J Travel Med 1998; 5:184-188.
2. Steinecket RS, Steinberg JP, Schwartz B, et al. Evaluation for acquisition of resistant pneumococcus and meningococcus in returning travelers from the 1992 Olympics in Barcelona, Spain. Clin Infect Dis 1995;20:731-732.
3. Barnett BJ, Harper L, Yang WM, Kozarsky PE. Experience of corporate medical assistance clinics during the Centennial Olympic Games, Atlanta, 1996. J Travel Med 2000;7:25-26.